Oncology

Oncology

Surgery & Therapy

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
Home Gateways Oncology
41-60 of 71 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/f1000research.130716.1
Clinical Practice Article metrics
Oncoplastic breast volume replacement with the use of lateral intercostal artery perforator flap
[version 1; peer review: 2 approved with reservations]
Sinta Chaira Maulanisa, I Gusti Ngurah Gunawan Wibisana
Peer Reviewers Dedy Hermansyah; Kanchana Wijesinghe
PUBLISHED 01 Mar 2023
https://doi.org/10.12688/f1000research.127528.1
Research Article metrics AWAITING PEER REVIEW
Impact of serum leptin and adiponectin levels on breast cancer in postmenopausal Iraqi women: an observational Study
[version 1; peer review: awaiting peer review]
Mohammed A. Abd, Shaymaa A. Abbas, Laith G. Shareef
Peer Reviewers Invited
PUBLISHED 23 Dec 2022
https://doi.org/10.12688/f1000research.108628.2
Review metrics
Revised
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
[version 2; peer review: 2 approved]
Freda Halim, Yohana Azhar, Suwarman ., Bethy Hernowo
Peer Reviewers Didik Setyo Heriyanto; Norbert Nass
LATEST VERSION PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.126754.1
Research Article metrics
Tumour cell suppression by spiroleucettadine through dual regulation of cell cycle and apoptosis
[version 1; peer review: 1 approved]
Ben Watts, Maddie Berry, Abigail Bland, Michael Badart, Bill Hawkins, John Ashton
Peer Reviewers Brad Sutherland
  • Funder
  • University of Otago
PUBLISHED 16 Nov 2022
https://doi.org/10.12688/f1000research.126462.1
Research Article metrics
PD-L1 expression as predictor of immunotherapy eligibility in penile squamous cell carcinoma patients
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Muhammad Haritsyah Warli, Fauriski Febrian Prapiska, Ginanda Putra Siregar, Bungaran Sihombing, Syah Mirsya Warli
Peer Reviewers Thomas S. Gerald; Jan Hrudka; Dr.Sourav Kumar Mishra
PUBLISHED 09 Nov 2022
https://doi.org/10.12688/f1000research.126905.1
Case Report metrics
Case Report: A pericardial effusion secondary to cardiac desmoplastic small round cell tumor
[version 1; peer review: 2 approved with reservations]
Nehemias Guevara, Jane Atallah, Mailing Flores Chang, Steven Epstein, Rocco Lafaro, Ilmana Fulger
Peer Reviewers Fernand Bteich; Madelyn Espinosa-Cotton
PUBLISHED 28 Oct 2022
https://doi.org/10.12688/f1000research.125335.1
Case Report metrics
Case Report: Localized Ewing’s sarcoma of the scapula in an adult
[version 1; peer review: 1 approved with reservations]
Rafik Elafram, Majdi Ben Romdhane, Nayssem Khassairi, Sarrah Ben Rjeb, Saiffallah Toumi, Majdi Sghaier
Peer Reviewers Iyad Sultan
PUBLISHED 10 Oct 2022
https://doi.org/10.12688/f1000research.125428.1
Research Article metrics AWAITING PEER REVIEW
Factors predicting complications, neurologic deterioration and mortality for patients with meningioma surgery: An observational study
[version 1; peer review: awaiting peer review]
Aji Setia Utama, Joni Wahyuhadi, Muhammad Arifin, Asra Al Fauzi, Pudji Lestari, Kurnia Kusumastuti, Makhyan Jibril Al-Farabi, Yusuf Mannagalli
Peer Reviewers Invited
PUBLISHED 27 Sep 2022
https://doi.org/10.12688/f1000research.108827.2
Research Article metrics
Revised
Assessing the anticancer effects of metformin
[version 2; peer review: 1 approved with reservations, 2 not approved]
Mohammed Yunus, Amr Zaher, Sajid Hussain, Karam Ali Alawami, Dhiyaa Jaber Alfaraj, Ahmed Mohammed Alqatari, Morteda Jasim Alsalim, Murtaja Zaki Almissri, Mohammed Abdul Lateef Junaid
Peer Reviewers Deqiang Huang; Divya Subramonian; Kasuni H.M. Akalanka
LATEST VERSION PUBLISHED 09 Aug 2022
https://doi.org/10.12688/f1000research.122368.1
Case Report metrics
Case Report: Ovarian fibroma: typical presentation with Meigs’s Syndrome
[version 1; peer review: 2 approved, 1 approved with reservations]
Dipesh Upreti, Dipesh Kumar Rohita, Shailendra Kumar Yadav, Niku Thapa
Peer Reviewers Irene Iavarone; Bijal Patel; Heera Shenoy
PUBLISHED 22 Jul 2022
https://doi.org/10.12688/f1000research.110320.2
Research Article metrics
Revised
Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy
[version 2; peer review: 2 approved, 1 approved with reservations]
Dwi Wahyunianto Hadisantoso, Dody Ranuhardy, Wulyo Rajabto, Aulia Rizka, Lyana Setiawan, Ikhwan Rinaldi, Arif Mansjoer, Erni Juwita Nelwan, Hamzah Shatri
Peer Reviewers Shinta Wardani; Hyewon Lee; Smita Kayal
LATEST VERSION PUBLISHED 01 Jul 2022
https://doi.org/10.12688/f1000research.110966.2
Research Article metrics
Revised
Establishment of diagnostic reference level and radiation dose variation in head & neck and pelvis treatment planning in radiation therapy computed tomography
[version 2; peer review: 1 approved]
Ms. Shreekripa Rao, Dr. Rajagopal Kadavigere, Dr. Krishna Sharan, Suresh Sukumar, Mr. Srinidhi GC, Mrs. Rechal Nisha Dsouza, Mr. Suman S
Peer Reviewers Rekha Reddy Buchapudi
  • Funder
  • Indian Council of Medical Research
LATEST VERSION PUBLISHED 26 May 2022
https://doi.org/10.12688/f1000research.20454.2
Opinion Article metrics
Revised
Time to initiate randomized controlled clinical trials with methadone in cancer patients
[version 2; peer review: 2 approved]
Hans-Joachim Kremer
Peer Reviewers Mary Lynn McPherson; Harald Köfeler
LATEST VERSION PUBLISHED 12 May 2022
https://doi.org/10.12688/f1000research.53875.2
Research Article metrics
Revised
Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain
[version 2; peer review: 2 approved]
Xavier Bonfill-Cosp, Ariadna Auladell-Rispau, Ignasi Gich, Javier Zamora, Luis Carlos Saiz, Jose Ignacio Pijoan, Iratxe Urreta, José Antonio Cordero
Peer Reviewers Helena Colom Codina; Philipp Dahm
  • Funder
  • Instituto de Salud Carlos III
LATEST VERSION PUBLISHED 21 Apr 2022
https://doi.org/10.12688/f1000research.110079.1
Research Article metrics
Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
[version 1; peer review: 1 approved, 2 approved with reservations]
Josephine Efraim, Castory Munisi, Auson Magige, Kelvin Msuya, Alphonce Ignace Marealle, Manase Kilonzi, Hamu Mlyuka, Wigilya Mikomangwa, Bertha Mallya, Wema Aswile, Kauke Bakari Zimbwe, Ritah Francis Mutagonda
Peer Reviewers Divya Subramonian; Sidharth Totadri; Paola Muggeo
PUBLISHED 06 Apr 2022
https://doi.org/10.12688/f1000research.27244.2
Case Report metrics
Revised
Case Report: Good responsiveness of metastatic sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation to immune checkpoint inhibitor after radical surgery and chemotherapy
[version 2; peer review: 2 approved]
Hyung Ho Lee, Hye Ju Kang, Weon Seo Park, Wonyoung Choi, Ho Kyung Seo, Sung Han Kim
Peer Reviewers Wan Song; Katsuhiro Ito
  • Funder
  • National Cancer Center, South Korea
LATEST VERSION PUBLISHED 31 Mar 2022
https://doi.org/10.12688/f1000research.108596.1
Research Article metrics
Diaphragm thickness, mobility and respiratory muscle strength in patients with head and neck cancer receiving chemoradiation therapy: A longitudinal pilot study
[version 1; peer review: 1 approved with reservations, 1 not approved]
Macrina D’souza, Stephen Samuel, Santosh Rai, Gopala Krishna Alaparthi, PU Prakash Saxena, Ravishankar Nagaraja
Peer Reviewers Asir John Samuel and Vencita Priyanka Aranha; Shane Patman
PUBLISHED 10 Mar 2022
https://doi.org/10.12688/f1000research.108908.1
Systematic Review metrics
Molecular mechanisms of flavonoids and their modulatory effects against breast cancer: A scoping review
[version 1; peer review: 2 approved with reservations, 1 not approved]
Mary Murithi, Esbon Wambugu, Steven Nyanjom, Victor Mobegi, Sayed Shahin, Francis Makokha
Peer Reviewers Muthi Ikawati; Sandip Patel; Nupur Mukherjee
PUBLISHED 09 Mar 2022
https://doi.org/10.12688/f1000research.75870.1
Research Article metrics
Effects of asparaginases and L-carnitine on Western-diet-induced hepatosteatosis in mice
[version 1; peer review: 1 approved, 2 approved with reservations]
Mona Ali Mahmoud Assar, Martina Hüffel, Mamdouh Afify, Ralf Weiskirchen, Albrecht Eisert, Rene Tolba, Julia Steitz
Peer Reviewers Matías A. Avila; Ruchi Bansal; Olamide B Adelusi
  • Funders
  • This work was supported with a stipend to Mona Ali Mahmoud Assar by the Egyptian cultural affairs and missions’ sector and ministry of higher education
  • European Union and NRW government
PUBLISHED 01 Feb 2022
https://doi.org/10.12688/f1000research.75922.1
Clinical Practice Article metrics PEER REVIEW DISCONTINUED
Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access? A clinical practice article
[version 1; peer review: 1 approved with reservations]
Victoria Eriksson, Elisabeth Eriksson, Amir Sherif
Peer Reviewers Katsuhiro Ito
PUBLISHED 13 Jan 2022
41-60 of 71 ARTICLES
Previous Next
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.